Clinical Trial Update: A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study of BL-M11D1 in combination with cytarabine plus daunorubicin or venetoclax plus azacitidine in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• BL-M11D1
• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING